Author Index
Search or browse for an author across our entire electronic archive
Search results for: Y
Results 241 - 250 of 435 shown below
Yen, S H
C H Yang, C M Tsai, L S Wang, Y C Lee, C J Chang, L T Lui, S H Yen, C Hsu, A L Cheng, M Y Liu, S C Chiang, Y M Chen, K T Luh, M H Huang, P-C Yang and R-P Perng
Gemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancer
doi:10.1038/sj.bjc.6600044
Abstract | Full article | PDF
Yen, W-C
W-C Yen, R Y Prudente, M R Corpuz, A Negro-Vilar and W W Lamph
A selective retinoid X receptor agonist bexarotene (LGD1069, targretin) inhibits angiogenesis and metastasis in solid tumours
advance online publication, 2006-02-21 00:00:00.000;
doi:10.1038/sj.bjc.6602995
Abstract | Full article | PDF
Yen, Y
G Somlo, J H Doroshow, T Synold, J Longmate, D Reardon, W Chow, S J Forman, L A Leong, K A Margolin, R J Morgan Jr, J W Raschko, S I Shibata, M L Tetef, Y Yen, N Kogut, J Schriber and J Alvarnas
High-dose paclitaxel in combination with doxorubicin, cyclophosphamide and peripheral blood progenitor cell rescue in patients with high-risk primary and responding metastatic breast carcinoma: toxicity profile, relationship to paclitaxel pharmacokinetics
doi:10.1054/bjoc.2001.1835
Yeo, W
J Bernhard, D Zahrieh, J J Zhang, G Martinelli, R Basser, C Hürny, J F Forbes, S Aebi, W Yeo, B Thürlimann, M D Green, M Colleoni, R D Gelber, M Castiglione-Gertsch, K N Price, A Goldhirsch and A S Coates
Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer
advance online publication, 2007-11-27 00:00:00.000;
doi:10.1038/sj.bjc.6604092
Abstract | Full article | PDF
Yeoh, K
C E Furneaux, E S Marshall, K Yeoh, S J Monteith, P J Mews, C A Sansur, R J Oskouian, K J Sharples and B C Baguley
Cell cycle times of short-term cultures of brain cancers as predictors of survival
advance online publication, 2008-10-14 00:00:00.000;
doi:10.1038/sj.bjc.6604716
Abstract | Full article | PDF
Yeoh, K G
S K Teh, W Zheng, K Y Ho, M Teh, K G Yeoh and Z Huang
Diagnostic potential of near-infrared Raman spectroscopy in the stomach: differentiating dysplasia from normal tissue
advance online publication, 2008-01-15 00:00:00.000;
doi:10.1038/sj.bjc.6604176
Abstract | Full article | PDF
Yeow, W-S
W-S Yeow, M F Ziauddin, J B Maxhimer, S Shamimi-Noori, A Baras, A Chua, D S Schrump and D M Nguyen
Potentiation of the anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the kinase inhibitor Staurosporine or its clinically relevant analogue UCN-01
doi:10.1038/sj.bjc.6603132
Abstract | Full article | PDF
Yeremin, L
R Chen-Shtoyerman, A Figer, H H Fidder, P Rath, L Yeremin, S Bar Meir, E Friedman and L Theodor
The frequency of the predominant Jewish mutations in BRCA1 and BRCA2 in unselected Ashkenazi colorectal cancer patients
doi:10.1054/bjoc.2000.1598
Yerushalmi, R
O Uziel, E Fenig, J Nordenberg, E Beery, H Reshef, J Sandbank, M Birenbaum, M Bakhanashvili, R Yerushalmi, D Luria and M Lahav
Imatinib mesylate (Gleevec) downregulates telomerase activity and inhibits proliferation in telomerase-expressing cell lines
advance online publication, 2005-05-03 00:00:00.000;
doi:10.1038/sj.bjc.6602592
Abstract | Full article | PDF
Yeung, B H Y
B H Y Yeung, K Y Wong, M C Lin, C K C Wong, T Mashima, T Tsuruo and A S T Wong
Chemosensitisation by manganese superoxide dismutase inhibition is caspase-9 dependent and involves extracellular signal-regulated kinase 1/2
advance online publication, 2008-07-01 00:00:00.000;
doi:10.1038/sj.bjc.6604477
Abstract | Full article | PDF
